Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,958.6
13.1 (0.45%)

 

  • STI Straits Times Index
    2,958.6
    13.1 (0.45%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,580.6
    5.3 (0.34%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,297.5
    -93.7 (-0.32%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,573.3
    3.9 (0.11%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,635.2
    89.0 (0.31%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,109.2
    -31.0 (-0.50%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 3,223.3M
  • Value: 1,250.2M
  • Rise: 216
  • Fall: 154
  • Unch: 407

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
China Star Food0.044-0.006
China Env Res0.023+0.010
Jiutian Chemical0.105-0.001
Asian Micro0.020-0.004
Artivision Tech0.012-
The Place Hldg0.145-0.020
Samko Timber0.046+0.008
MMP Resources^0.009-0.001
Guoan Intl0.014+0.004
Oceanus^0.052+0.001

World Indices

World Indices
Name Last Change
Nasdaq 13,626.1 -9.9
HSI 29,297.5 -93.7
HSCEI 11,651.2 -44.2
Jakarta 6,109.2 -31.0
Nikkei 225 28,635.2 +89.0
SSE Comp 3,573.3 +3.9
Shanghai A 3,745.6 +4.1
Shanghai B 247.5 +1.7
KOSPI 3,122.6 -17.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

IMMUNOVANT INC IMMUNOVANT
Updated on 26 Jan 2021 (End of trading day)
Last (USD): 39.640 Change: -2.100 High: 41.970 Remarks: -
Change (%): -5.03 Low: 39.490
Open 41.740 Yesterday's Close 41.74
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 294,205 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.67763 Trailing EPS (USD) e -0.80987 NAV (USD) b 4.4748
PE a - Trailing PE f - Price / NAV b 8.8585
Dividend (USD) d - Cash In Hand (USD) g 4.5357 Issued & Paid-up Shares c 97,971,200
Dividend Yield (%) d - Price / Cash In Hand g 8.740 Treasury Shares h -
Market Cap (M) 3,883.578 Enterprise Value (M) 3,443.121
Piotroski F Score 2 Exchange Code IMVT Par Value ( $ ) n.a.
52 Weeks Volatility (%) 82.32 Free Float (%) 41.2
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 15 Jan 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 12 Nov 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference IMMUNOVANT INC NASDAQ 3,883.578 - - 8.8585 -
Industry Biotechnology NASDAQ 3,232.152 506.525 - 7.7542 0.527
Local Peer AMGEN INC NASDAQ 150,548.903 19.198 20.477 13.7375 2.278
Local Peer GILEAD SCIENCES INC NASDAQ 83,610.451 15.524 65.939 4.7928 3.816
Local Peer VERTEX PHARMACEUTICAL NASDAQ 61,795.430 52.511 22.966 7.5977 -
Local Peer ILLUMINA INC NASDAQ 61,400.300 61.278 96.239 13.0639 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 58,058.718 27.441 18.396 5.7339 -
Local Peer MODERNA INC NASDAQ 60,120.220 - - 21.7843 -
Local Peer BIOGEN INC NASDAQ 41,805.123 7.099 8.225 3.8858 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 35,378.122 14.715 36.983 3.1944 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 32,676.845 - - 7.6214 -
Local Peer SEAGEN INC NASDAQ 31,128.028 - 65.893 13.7855 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 25,315.408 - - 23.2709 -
Local Peer EXACT SCIENCES CORP NASDAQ 22,429.591 - - 9.5972 -
Other Local Peers INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIO-TECHNE CORP (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ACCELERON PHARMA (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), SEER INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), INSMED INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ALKERMES PLC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), VERACYTE INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALLOVIR INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), NANTKWEST INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), VIELA BIO INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), REGENXBIO INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), PERSONALIS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), BIOATLA INC (NASDAQ), NKARTA INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), CYTOKINETICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), ALECTOR INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), MACROGENICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), VAXCYTE INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), EPIZYME INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), COMPUGEN (NASDAQ), MERUS B V (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), HUMANIGEN INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), PASSAGE BIO INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), KADMON HLDGS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), CURIS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), AFFIMED N V (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CHIMERIX INC (NASDAQ), AGENUS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), IMMATICS N V (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ARDELYX INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), AVROBIO INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), AKOUOS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ONCORUS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), ATRECA INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), PROTHENA CORP PLC (NASDAQ), GERON CORP (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), IVERIC BIO INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), BIOVIE INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), ATHERSYS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), NEXTCURE INC (NASDAQ), TREVENA INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CABALETTA BIO INC (NASDAQ), OCUGEN INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), KAMADA LTD (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ADICET BIO INC (NASDAQ), INMUNE BIO INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), METACRINE INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), IMV INC (NASDAQ), EVOGENE LTD (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), SESEN BIO INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), CHIASMA INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), OTONOMY INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), AXCELLA HEALTH INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), GLYCOMIMETICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), IMMUNOME INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), EQUILLIUM INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), ORGENESIS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), INFLARX N V (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), CONTRAFECT CORP (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), COHBAR INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), ARAVIVE INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ADVAXIS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), SOLIGENIX INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), PRECIPIO INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ATYR PHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), HISTOGEN INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENESTECH INC (NASDAQ)
Global Peer CSL LTD ASX 125,208.845 39.922 39.922 13.2068 1.066
Global Peer WUXI BIO HKEx 457,363.738 397.851 317.634 30.6176 -
Global Peer BEIGENE HKEx 246,812.772 - - 7.4278 -
Global Peer SINO BIOPHARM HKEx 141,291.886 46.034 55.213 3.9202 0.710
Global Peer ZAI LAB-SB HKEx 114,431.460 - - 31.7198 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 5,796.512 106.358 34.793 4.6317 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 20,565.136 - - 2.8127 -
Global Peer ARCUS BIOSCIENCES INC NYSE 2,339.186 - - 4.2967 -
Global Peer 3SBIO HKEx 18,949.820 17.163 12.621 1.6200 -
Other Global Peers JW THERAP-B (HKEx), JACOBIO-B (HKEx), VIVA BIOTECH (HKEx), MYOVANT SCIENCES LTD (NYSE), ALPHAMAB-B (HKEx), FRONTAGE (HKEx), JHBP-B (HKEx), HAOHAI BIOTEC (HKEx), ASCENTAGE-B (HKEx), POLYNOVO LIMITED (ASX), MESOBLAST LTD (ASX), TELIX PHARMACEUTIC (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), DPHARMA (Bursa), KINTOR PHARMA-B (HKEx), SQZ BIOTECHNOLOGIES CO (NYSE), SINOMAB BIO-B (HKEx), OPTHEA LIMITED (ASX), ASCLETIS-B (HKEx), IMUGENE LIMITED (ASX), LEE'S PHARM (HKEx), LINEAGE CELL THERAPEUTICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), ESSEX BIO-TECH (HKEx), NANOVIRICIDES INC (NYSE American), IMMUTEP LTD (ASX), NEXT SCIENCE LTD (ASX), ANTEOTECH LIMITED (ASX), PALATIN TECHNOLOGIES INC (NYSE American), IBIO INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), NEUREN PHARMACEUTICALS LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), BIONOMICS LTD (ASX), UNI-BIO GROUP (HKEx), GENETIC TECHNOLOGIES (ASX), CYNATA THERAPEUTICS LTD (ASX), LEAF RESOURCES LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), REGENT PACIFIC (HKEx), MEMPHASYS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ORAGENICS INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), PATRYS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), BIOTRON (ASX), CT ENTERPRISE (HKEx), Suntar Eco-City (SGX), CONSTELLATION TECHNOLOGIES LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CONTANGO ASSET MANAGEMENT LIMITED (ASX), REGENEUS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), ADALTA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), RHINOMED LIMITED (ASX), ACTINOGEN MEDICAL LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NANOLLOSE LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), CRYOSITE (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --2.810
-6.62 %
10 Days --4.510
-10.22 %
20 Days --9.690
-19.64 %
Medium Term Return 3 Months --2.330
-5.55 %
6 Months -+16.160
+68.82 %
1 Year -+23.680
+148.37 %
Annualised Return Annualised --
+148.37 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 8.340 - 53.750 Change From 1 Year Low +31.300 % Change From 1 Year Low (%) +375.30
Change From 1 Year High -14.110 % Change From 1 Year High (%) -26.25
2 Years Range 8.340 - 53.750 Change From 2 Years Low +31.300 % Change From 2 Years Low (%) +375.30
Change From 2 Years High -14.110 % Change From 2 Years High (%) -26.25
5 Years Range 8.340 - 53.750 Change From 5 Years Low +31.300 % Change From 5 Years Low (%) +375.30
Change From 5 Years High -14.110 % Change From 5 Years High (%) -26.25
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Immunovant, Inc. is a clinical-stage biopharmaceutical company. It focuses on enabling normal lives for patients with autoimmune diseases. The company was founded in 2018 and is headquartered in New York, NY.

Historical Price Data

Date Open High Low Close Volume VWAP
26 Jan 2021 41.740 41.970 39.490 39.640 294,205 -
25 Jan 2021 42.010 42.230 39.710 41.740 352,094 -
22 Jan 2021 41.250 43.580 41.250 42.190 333,545 -
21 Jan 2021 42.570 42.820 40.340 41.610 646,388 -
20 Jan 2021 44.910 45.420 42.240 42.450 489,965 -
19 Jan 2021 44.480 45.940 44.000 44.650 304,779 -
15 Jan 2021 44.460 44.840 42.470 44.100 320,836 -
14 Jan 2021 45.540 46.520 44.200 44.510 459,101 -
13 Jan 2021 46.600 46.850 43.710 44.150 349,908 -
12 Jan 2021 47.010 48.485 45.605 46.950 270,182 -
11 Jan 2021 49.050 50.320 46.440 46.770 352,193 -
08 Jan 2021 47.530 49.870 47.440 49.600 345,041 -
07 Jan 2021 46.030 48.360 46.030 47.280 498,530 -
06 Jan 2021 45.300 46.890 44.000 46.140 408,605 -
05 Jan 2021 45.260 46.320 44.790 45.440 282,271 -
04 Jan 2021 45.680 47.540 44.450 45.390 359,879 -
31 Dec 2020 49.160 49.210 45.850 46.190 408,603 -
30 Dec 2020 50.540 50.540 48.330 49.330 176,265 -
29 Dec 2020 48.310 49.440 47.680 48.170 198,441 -
28 Dec 2020 50.900 50.900 47.910 48.220 296,622 -
24 Dec 2020 49.090 50.720 48.790 49.780 85,041 -
23 Dec 2020 48.045 49.705 47.413 49.010 255,615 -
Summary
Current 2 Weeks
(12 Jan 2021 to 26 Jan 2021)
47.010 48.485 39.490 39.640 3,821,003 -
Previous 2 Weeks
(28 Dec 2020 to 11 Jan 2021)
50.900 50.900 39.490 46.770 3,326,450 -
4 Weeks from
(27 Nov 2020 to 24 Dec 2020)
49.240 51.870 39.490 49.780 10,731,729 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.